Publication:
Curcumin and tetrahydrocurcumin restore the impairment of endothelium-dependent vasorelaxation induced by homocysteine thiolactone in rat aortic rings

dc.contributor.authorTep-Areenan P.
dc.contributor.authorSuksamrarn A.
dc.date.accessioned2021-04-05T03:34:24Z
dc.date.available2021-04-05T03:34:24Z
dc.date.issued2012
dc.date.issuedBE2555
dc.description.abstractThe aim of the present study was to investigate the effects of curcumin and Terra Hydro Curcumin (THC) on the inhibition of endothelium-dependent vasorelaxation of the isolated rat aorta by Homocysteine Thiolactone (HTL). Carbachol, an endothelium-dependent vasodilator, caused concentration-dependent vasorelaxation in rat aortic rings. Exposure of aortic rings to HTL (0.3 and 1 mM) for 90 min significantly inhibited endothelium-dependent vasorelaxation to carbachol. In addition, contractions induced by methoxamine were significantly reduced after pretreatment with 3 mM HTL. Curcumin (10 and 30 μM) significantly restored carbachol-induced vasorelaxation inhibited by HTL (1 mM). Similar effects were observed after pretreatment of aortic rings with THC (10 and 30 μM). Moreover, HTL-induced impairment of vasorelaxation to carbachol could be blocked by either L-arginine (3 mM), a precursor of nitric oxide or superoxide dismutase (SOD, 200 U mL _1), a scavenger of superoxide anion. These results demonstrate that impairment of endothelium-dependent vasorelaxation induced by HTL is due to a reduction of nitric oxide and the generation of oxygen free radicals. Interestingly, curcumin and THC could restore endothelial dysfunction induced by HTL which may be related to their antioxidant properties. The present study provides pharmacological data to support the hypothesis that curcumin and THC have vasoprotective effects in hyperhomocysteinemia. © 2012 Asian Network for Scientific Information.
dc.format.mimetypeapplication/pdf
dc.identifier.citationInternational Journal of Pharmacology. Vol 8, No.2 (2012), p.128-133
dc.identifier.doi10.3923/ijp.2012.128.133
dc.identifier.issn18117775
dc.identifier.other2-s2.0-84858044200
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7095
dc.rights.holderScopus
dc.subject.otherAntioxidant
dc.subject.otherArginine
dc.subject.otherCarbachol
dc.subject.otherCurcumin
dc.subject.otherHomocysteine thiolactone
dc.subject.otherMethoxamine
dc.subject.otherNitric oxide
dc.subject.otherOxygen radical
dc.subject.otherSuperoxide dismutase
dc.subject.otherTetrahydrocurcumin
dc.subject.otherUnclassified drug
dc.subject.otherAnimal experiment
dc.subject.otherAnimal model
dc.subject.otherAnimal tissue
dc.subject.otherAntioxidant activity
dc.subject.otherAorta constriction
dc.subject.otherArticle
dc.subject.otherConcentration response
dc.subject.otherControlled study
dc.subject.otherDrug efficacy
dc.subject.otherDrug structure
dc.subject.otherEndothelial dysfunction
dc.subject.otherLong term exposure
dc.subject.otherMale
dc.subject.otherNonhuman
dc.subject.otherRat
dc.subject.otherStructure analysis
dc.subject.otherVascular endothelium
dc.subject.otherVascular ring
dc.subject.otherVasodilatation
dc.titleCurcumin and tetrahydrocurcumin restore the impairment of endothelium-dependent vasorelaxation induced by homocysteine thiolactone in rat aortic rings
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84858044200&doi=10.3923%2fijp.2012.128.133&partnerID=40&md5=64b6df8f189c557ed7f0cefe03d6bb53

Files